U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07629193) titled 'Liver Transplant for Hepatocellular Carcinoma' on April 20.
Brief Summary: This research focuses on analysing data collected as part of your usual care. Currently, the eligibility of patients with hepatocellular carcinoma for liver transplantation is based on the calculation of scores. These scores mainly take into account the volume of the tumour measured by imaging, one or more blood markers and the patient's general condition.
However, these scores do not take into account:
* the concept of downstaging (i.e. the prior reduction of tumour volume through locoregional or systemic treatments, which subsequently allows access to LT),...